| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.43 | 0.03 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |